Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . November 7th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Diagnostics - Fluorescent nanoparticle labels facilitate rapid screening for hepatitis B infection
Hematology - Patient host factors prevent GB virus C, hepatitis, and HIV infection in exposed hemophiliacs
Hepatitis C Therapy - Interleukin-10 receptor blockade may augment therapy targeting hepatitis C
Hepatocellular Carcinoma - Transcatheter arterial chemoembolization rarely aggravates hepatitis B-related liver disease
Vaccine Safety - Limulus amoebocyte lysate assay detects endotoxin in hepatitis B virus vaccine
Adverse Drug Reactions - Mitochondrial permeability transition main effect of mitochondrial uncoupling, ROS is secondary
Analgesia - Pain scores look similar in patients given different liver biopsy procedures
Autoimmune Disease - Budesonide sends previously untreated autoimmune hepatitis into remission
Cirrhosis - Select genotypes underlie cirrhosis progression in hereditary hemochromatosis
Diagnostics - HCV-RNA transcription-mediated amplification detects infection in hemodialysis patients
Diagnostics - PCR-based methods show variability in detecting hepatitis B virus precore region mutants
Drug Development - Biotech company to focus on developing hepatitis C, arthritis, CF drugs
Drug Resistance - Protein is undetectable in patients with no response to hepatitis C therapy
Enzymology - Injection drug users with chronic hepatitis C show fluctuating liver enzyme levels
Gastroenterology - Leptin from T cells is not involved in hepatic or intestinal inflammation
Gene Research - Gene expression profiles change in patients with stage I primary biliary cirrhosis
Healthcare Coverage - Many hepatitis C virus-positive individuals lack health insurance
Hepatitis A Treatment - GSK's hepatitis vaccine has been approved for use in children12 months and older
Hepatitis B Prevention - Hepatitis B vaccine programs in Germany should be extended to include susceptible populations
Hepatitis B Therapy - RNA interference blocks hepatitis B virus production
Hepatitis B Vaccine - Biopharma company signs distribution agreement for hepatitis B vaccine in China
Hepatitis C Therapy - Cyclosporin A blocks cyclophilins to suppress hepatitis C virus replication
Hepatitis C Treatment - Latin Americans with chronic hepatitis C are less likely to initiate or continue therapy
Hepatitis C Vaccine - Merck and Co. to develop adenovirus-based vaccine against hepatitis C
Hepatitis C Virus - Tattooing practices foster hepatitis C transmission on the Texas-Mexico border
Hepatocellular Carcinoma - Patients with hepatocellular carcinoma bear multiple hepatitis B X gene mutations
Hepatocellular Carcinoma - Patients with untreated hepatocellular carcinoma face grim outcomes despite supportive treatment
Liver Cancer - Bcl-2 expression rises in patients with chronic liver diseases
Membranous Nephropathy - Lamivudine improves renal status in patients with hepatitis B-associated kidney disease
Stem Cell Research - CD45+ liver subpopulation tip cells generated from bone marrow stem cells
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
